Advertisement
News
Subscribe to MDT Magazine News

Amarin Prices Public Offering of American Depositary Shares

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

MYSTIC, Conn. and DUBLIN, Jan. 6, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced the pricing of an underwritten public offering of 12,000,000 American Depositary Shares...

TOPICS:

The Center for Business Intelligence (CBI) Announces Virtual Conference on Imaging for Drug Development

January 6, 2011 4:33 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Jan. 6, 2011 /- The Center for Business Intelligence (CBI) is pleased to announce Preclinical and Clinical Imaging for Drug Development being held February 23, 2011 from 9:30 am - 6:00 pm EST. CBI provides a unique opportunity to bring together a diverse collection of...

TOPICS:

Former FDA Commissioner Joins Bexion Pharmaceuticals Board

January 6, 2011 4:32 am | by Bio-Medicine.Org | Comments

COVINGTON, Ky., Jan. 6, 2011 /- Bexion Pharmaceuticals, LLC announced today that it has added Lester Crawford, D.V.M., and Ph.D. to its Board of Directors. Dr. Crawford has had a distinguished career in the public and private sectors as well as academia. Over ten years of his career were...

TOPICS:
Advertisement

OnePartner selects MobileMD for Health Information Exchange

January 6, 2011 3:36 am | by Bio-Medicine.Org | Comments

DUFFIELD, Va. and WARMINSTER, Pa., Jan. 6, 2011 /- OnePartner, LLC selects MobileMD, Inc. for Health Information Exchange (HIE) component of innovative, cost effective, and rapidly deployed Electronic Health Record (EHR) solution. Leveraging popular cloud computing techniques designed...

TOPICS:

Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million

January 6, 2011 3:36 am | by Bio-Medicine.Org | Comments

FRANKLIN, Mass., Jan. 6, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...

TOPICS:

Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity

January 6, 2011 3:35 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Jan. 6, 2011 /- Viveve, Inc. , a development stage women's health company, announced today that it has received the European CE (Conformite Europeenne) mark for the use of its Viveve System for the non-surgical treatment of laxity of the vaginal introitus (opening),...

TOPICS:

Boston Scientific buys Intelect Medical for $60M

January 6, 2011 3:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. has acquired Intelect Medical Inc., a Boston-based company that recently moved here from Ohio, and is developing technologies for deep brain stimulation, for $60 million in cash.

TOPICS:

IRIDEX to Present at the OneMedForum San Francisco 2011 Conference

January 6, 2011 3:35 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 6, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that management will present at the OneMedForum San Francisco 2011 Conference at 8:45 a.m. PST on Tuesday, January 11.  The conference will be held on January 11-13 at the Sir Francis Drake...

TOPICS:
Advertisement

CeNeRx Initiates Phase II Trial of TriRimaâ„¢ as Monotherapy in Treatment Resistant Depression

January 6, 2011 3:34 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2011 /- CeNeRx BioPharma, Inc., today reported that it has initiated a Phase II trial of its new formulation of TriRima ™, the company's novel antidepressant in development as monotherapy for treatment resistant depression.  CeNeRx also...

TOPICS:

Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device

January 6, 2011 3:33 am | by Bio-Medicine.Org | Comments

STEVENSVILLE, Md., Jan. 6, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest®, a device designed for homecare and other low acuity environments. The Flowrest® device delivers warmed humidified...

TOPICS:

Sun Healthcare sets 2011 guidance

January 6, 2011 2:45 am | by The Associated Press | Comments

Health care facility operator Sun Healthcare Group Inc. said Thursday it expects earnings of between $1.30 and $1.45 per share in 2011, while expanding capacity.The company based in Irvine, Calif., also expects revenue between $1.95 billion and $2 billion.Analysts polled by Thomson Reuters expect...

Okla. inmate to be executed for 1995 murder

January 5, 2011 11:45 pm | by TIM TALLEY - Associated Press - Associated Press | Comments

An Oklahoma death row inmate convicted of the baseball-beating death of a convenience store work almost 16 years ago is scheduled to become the first person executed in the U.S. this year.Billy Don Alverson, 39, was convicted of first-degree murder and sentenced to die for the Feb, 26, 1995,...

Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range

January 5, 2011 11:34 pm | by Bio-Medicine.Org | Comments

BEIJING, Jan. 6, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the fourth quarter and full year ended December 31, 2010. A conference call to discuss these...

TOPICS:

Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics

January 5, 2011 7:36 pm | by EurekAlert | Comments

(Tufts University, Health Sciences) The Jackson Laboratory, Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine announce a new track for Ph.D. students in mammalian genetics. The joint track offers students in-depth research and training...

TOPICS:

Nanocarriers Come Through

January 5, 2011 7:35 pm | by Massachusetts Institute of Technology | Comments

Tiny Trojan horses deliver a cancer drug to cell nuclei.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading